Business
Merck & Co. agreed to buy Cubist Pharmaceuticals Inc. for $8.4 billion in cash to add products to help fight the growing threat of drug-resistant bacteria.
Dec. 8, 2014
Science & Medicine
The FDA warns about pneumonia caused by antibiotic Cubicin
July 29, 2010
The biotechnology sector, a star for much of this year but another victim of the latest tech-stock slide, may get a boost next week as a major industry conference gets underway.
Nov. 23, 2000
Culture Monster Blog
This article was originally on a blog post platform and may be missing photos, graphics or links.
Nov. 4, 2011
Entertainment & Arts
There are no losers among entrants in the California Museum of Photography’s annual holiday greeting card competition.
Nov. 27, 1992
Italo Scanga, an innovative neo-Dadaist, neo-Expressionist and neo-Cubist multimedia artist who made sculptures of ordinary objects and created prints, glass and ceramic works, has died.
July 31, 2001
In Santa Monica, a cubist design takes flight
May 14, 2011
March 18, 2017
The deal for the San Diego company, now testing a treatment for blindness, would be worth $527 million.
Jan. 21, 2005
As the threat of resistant bacteria grows, researchers are turning to soil, lichens and seaweed for new antibiotics.
March 13, 2006